332
Views
19
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Preseasonal prophylactic treatment with antihistamines suppresses IL−5 but not IL-33 mRNA expression in the nasal mucosa of patients with seasonal allergic rhinitis caused by Japanese cedar pollen

, , , , , & show all
Pages 434-438 | Received 16 Sep 2011, Accepted 13 Nov 2011, Published online: 04 Jan 2012

References

  • Stern MA, Darnel R, Tudor D. Can an antihistamine delay appearance of hay fever symptoms when given prior to pollen season? Allergy 1997;52:440–4.
  • Kurowski M, Kuna O, Gorski P. Montelukast plus cetirizine in the prophylactic treatment of seasonal allergic rhinitis: influence on clinical symptoms and nasal allergic inflammation. Allergy 2004;59:280–8.
  • Okubo K, Kurono Y, Fujieda S, Ogino S, Uchio E, Odajima H, Japanese guideline for allergic rhinitis. Allergol Int 2011;60:171–89.
  • Mizuguchi H, Kitamura Y, Kondo Y, Kuroda W, Yoshida H, Miyamoto Y, Pre-seasonal prophylactic treatment with antihistamines suppresses histamine H1 receptor mRNA expression in the nasal mucosa of patients with pollinosis. Methods Find Exp Clin Pharmacol 2010;32:745–8.
  • Igaz P, Novák I, Lázaár E, Horváth B, Héninger E, Falus A. Bidirectional communication between histamine and cytokines. Inflamm Res 2001;50:123–8.
  • Marone G, Granata F, Spadaro G, Genovese A, Triggiani M. The histamine-cytokine network in allergic inflammation. J Allergy Clin Immunol 2003;12(Suppl 4):S83–8.
  • Packard KA, Khan MM. Effects of histamine on Th1/Th2 cytokine balance. Int Immunopharmacol 2003;3:909–20.
  • Kouro T, Takatsu K. IL-5- and eosinophil-mediated inflammation: from discovery to therapy. Int Immunol 2009;21:1303–9.
  • Pelikan Z, Pelikan-Filipek M. Cytologic changes in the nasal secretions during the late nasal response. J Allergy Clin Immunol 1989;83:1068–79.
  • Pipkorn U, Karlsson G, Enerback L. The cellular response of the human allergic mucosa to natural allergen exposure. J Allergy Clin Immunol 1988;82:1046–54.
  • Munakata Y, Umezawa Y, Iwata S, Dong RP, Yoshida S, Ishii T, Specific inhibition of TH2-type cytokine production from human peripheral T cells by terfenadine in vitro. Clin Exp Allergy 1999;29:1281–6.
  • De Vos C, Joseph M, Leprevost C, Vorng H, Tomassini M, Capron M, Inhibition of human eosinophil chemotaxis and of the IgE-dependent stimulation of human blood platelets by cetirizine. Int Arch Allergy Appl Immunol 1989;88:212–15.
  • Das AK, Yoshimura S, Mishima R, Fujimoto K, Mizuguchi H, Dev S, Stimulation of histamine H1 receptor up-regulates histamine H1 receptor itself through activation of receptor gene transcription. J Pharmacol Sci 2007;103:374–82.
  • Mizuguchi H, Hatano M, Matsushita C, Umehara H, Kuroda W, Kitamura Repeated pre-treatment with antihistamines suppresses transcriptional up-regulations of histamine H1 receptor and interleukin-4 genes in toluene-2,4-diisocyanate-sensitized rats. J Pharmacol Sci 2008;108:480–6.
  • Zheng W, Flavell RA. The transcription factor GATA-3 is necessary and sufficient for TH2 cytokine gene expression in CD4 T cells. Cell 1997;89:587–96.
  • Barnes PJ. Role of GATA-3 in allergic diseases. Curr Mol Med 2008;8:330–4.
  • Murphy KM, Reiner SL. The lineage decisions of helper T cells. Nat Rev Immunol 2002;2:933–44.
  • Murphy KM, Ouyang J, Farrar D, Yang J, Ranganath S, Asnagli H, Signaling and transcription in T helper development. Annu Rev Immunol 2000;18:451–94.
  • Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan TK, IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005;23:479–90.
  • Sakashita M, Yoshimoto T, Hirota T, Harada M, Okubo K, Osawa Y, Association of serum interleukin-33 level and the interleukin-33 genetic variant with Japanese cedar pollinosis. Clin Exp Allergy 2008;38:1875–81.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.